Literature DB >> 28509220

A case presenting with the possible relationship between myeloperoxidase-antineutrophil cytoplasmic antibody-associated glomerulonephritis and membranous changes of the glomerular basement membrane.

Satoko Uyama1, Naro Ohashi2, Takamasa Iwakura1, Masafumi Ono1, Tomoyuki Fujikura1, Yukitoshi Sakao3, Hideo Yasuda1, Akihiko Kato3, Yoshihide Fujigaki1.   

Abstract

A 72-year-old woman exhibited elevated serum myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) levels since 2006. Her serum creatinine (sCr) levels increased from 0.5 to 1.62 mg/dl in a stepwise pattern with proteinuria and hematuria up to January 2011. Renal biopsy indicated global sclerosis (14 %), fibrocellular crescents (28 %), and Swiss cheese-like appearance of the glomerular basement membrane (GBM) on light microscopy. IgG4 staining was negative. Immunofluorescent examination indicated granular staining with IgG and C3 along the GBM. MPO-ANCA-associated glomerulonephritis with membranous nephropathy (MN) was diagnosed. As chronic changes were relatively evident in the renal biopsy specimen without acute augmentation of renal function, immunosuppressive therapy was not administered. Thereafter, rapidly progressive renal dysfunction occurred (sCr, 3.67 mg/dl in May 2011) with proteinuria (~2 g/day), hematuria, and elevated serum MPO-ANCA levels. Therefore, a second renal biopsy was performed in May 2011, indicating global sclerosis (42 %) and cellular crescents (35 %) on light microscopy. Electron microscopy indicated electron-dense deposits in the GBM and mesangial lesions. Steroid therapy was subsequently initiated, and the patient's renal function partially improved. MPO-ANCA levels decreased to within normal limits and hematuria disappeared. MPO-ANCA-associated glomerulonephritis with MN is a rare dual glomerulopathy. However, complication should be considered when urinary protein appears in large amounts. Secondary MN was suspected due to the lack of IgG4 staining and distribution of electron-dense deposits to the mesangial lesion. Renal dysfunction occurring in a stepwise pattern may be attributed to intermittent augmentation in MPO-ANCA-associated glomerulonephritis.

Entities:  

Keywords:  MPO-ANCA-associated glomerulonephritis; Membranous nephropathy; Renal dysfunction in a stepwise pattern

Year:  2012        PMID: 28509220      PMCID: PMC5411520          DOI: 10.1007/s13730-012-0039-9

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  19 in total

1.  Membranous nephropathy and anti-neutrophil cytoplasmic antibody-associated glomerulonephritis: a report of 2 cases.

Authors:  K M Dwyer; J W Agar; P A Hill; B F Murphy
Journal:  Clin Nephrol       Date:  2001-11       Impact factor: 0.975

Review 2.  ANCA-positive vasculitis.

Authors:  Lavanya Kamesh; Lorraine Harper; Caroline O S Savage
Journal:  J Am Soc Nephrol       Date:  2002-07       Impact factor: 10.121

3.  Membranous glomerulopathy induced by myeloperoxidase-anti-neutrophil cytoplasmic antibody-related crescentic glomerulonephritis.

Authors:  Tatsuya Suwabe; Yoshifumi Ubara; Tetsuo Tagami; Naoki Sawa; Junichi Hoshino; Hideyuki Katori; Fumi Takemoto; Shigeko Hara; Kumi Aita; Shigeo Hara; Kenmei Takaichi
Journal:  Intern Med       Date:  2005-08       Impact factor: 1.271

4.  Crescentic glomerulonephritis with a paucity of glomerular immunoglobulin localization.

Authors:  A A Harris; R J Falk; J C Jennette
Journal:  Am J Kidney Dis       Date:  1998-07       Impact factor: 8.860

5.  Glomerular and serum IgG subclasses in diffuse proliferative lupus nephritis, membranous lupus nephritis, and idiopathic membranous nephropathy.

Authors:  Aki Kuroki; Takanori Shibata; Hirokazu Honda; Daisuke Totsuka; Kenji Kobayashi; Tetsuzo Sugisaki
Journal:  Intern Med       Date:  2002-11       Impact factor: 1.271

Review 6.  Association of vasculitic glomerulonephritis with membranous nephropathy: a report of 10 cases.

Authors:  W Y Tse; A J Howie; D Adu; C O Savage; N T Richards; D C Wheeler; J Michael
Journal:  Nephrol Dial Transplant       Date:  1997-05       Impact factor: 5.992

7.  Myeloperoxidase antineutrophil cytoplasmic antibody-positive necrotizing crescentic glomerulonephritis and membranous glomerulonephropathy.

Authors:  Y Taniguchi; N Yorioka; J Kumagai; T Ito; M Yamakido; T Taguchi
Journal:  Clin Nephrol       Date:  1999-10       Impact factor: 0.975

8.  Detection of myeloperoxidase in membranous nephropathy-like deposits in patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.

Authors:  Kikuno Hanamura; Akihiro Tojo; Satoshi Kinugasa; Kensuke Asaba; Maristela Lika Onozato; Hiroshi Uozaki; Masashi Fukayama; Toshiro Fujita
Journal:  Hum Pathol       Date:  2011-02-02       Impact factor: 3.466

9.  Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.

Authors:  Alenka Vizjak; Tomaz Rott; Mira Koselj-Kajtna; Blaz Rozman; Stasa Kaplan-Pavlovcic; Dusan Ferluga
Journal:  Am J Kidney Dis       Date:  2003-03       Impact factor: 8.860

10.  Membranous glomerulonephritis with ANCA-associated necrotizing and crescentic glomerulonephritis.

Authors:  Samih H Nasr; Samar M Said; Anthony M Valeri; Michael B Stokes; Naveed N Masani; Vivette D D'Agati; Glen S Markowitz
Journal:  Clin J Am Soc Nephrol       Date:  2009-01-21       Impact factor: 8.237

View more
  1 in total

1.  Meta-Analytical Accuracy of ANCA Renal Risk Score for Prediction of Renal Outcome in Patients With ANCA-Associated Glomerulonephritis.

Authors:  Mengdi Xia; Ruiran Yu; Zaiqiong Zheng; Huan Li; Jie Feng; Xisheng Xie; Dongming Chen
Journal:  Front Med (Lausanne)       Date:  2022-01-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.